BidSonarBidSonar
ContractsGrantsOrganisationsSectors
BidSonarBidSonar·Built by Hypership
SourcesPrivacyTermsCookies

BidSonar is an independent index of public-sector opportunities. We aggregate data from official sources and are not affiliated with any procurement body. Data is licensed under the Open Government Licence v3.0 and the EU TED reuse notice.

    ContractsDenosumab Therapy Outpatient Services and Shared Care Documentation - Basildon and Brentwood
    Awarded contract

    Denosumab Therapy Outpatient Services and Shared Care Documentation - Basildon and Brentwood

    Status
    Awarded
    Published 18 Aug 2026

    Two-month urgent contract to provide Denosumab therapy to 100-150 outpatients and prepare shared care documentation for 700 patients in Essex, valued at £20,000.

    🇬🇧United Kingdom· East of EnglandPublished 18 Aug 2026· 3 days agoviaFind a Tender
    Status
    Awarded
    Published 18 Aug 2026

    Decision brief

    4 fields
    • Contract value
      Not disclosed
      Source did not declare a figure
    • Closing date
      Rolling
      No closing date published
    • Sector
      Healthcare & Medical
      Browse related listings
    • Location
      🇬🇧United Kingdom
      East of England

    Suppliers

    1 supplier
    • CH
      Cora Health MSK Ltd
    Lead contractor

    Lifecycle

    Awarded

    Contract awarded. Originally published 3 days ago.

    18 August 2026
    Awarded — no open tender advertised

    Brief

    NHS Essex Integrated Care Board seeks a qualified provider to deliver Denosumab therapy to outpatients and prepare shared care documentation for primary care in Basildon and Brentwood. This short-term contract (15 April 2026 to 30 June 2026) addresses an urgent gap in service delivery. The provider must: (1) administer Denosumab injections to approximately 100-150 current patients over 6 weeks to ensure continuity of care, and (2) complete and supply shared care documentation for approximately 700 patients in chronological order to facilitate handover to primary care. The contract value is £20,000, comprising approximately £7,950 for therapy administration (£53 per patient) and £12,000 for documentation preparation (£20 per record). This urgent award was made under Regulation 14 due to delays in primary care capacity to assume this responsibility within the originally planned timescale.

    Track record

    3 awards · 3 winners
    Open field

    No single supplier dominates the field.

    In this category, NHS Essex Integrated Care Booard has awarded 3 contracts to 3 suppliers.

    Who wins here
    1. Cora Health MSK Ltd1× · 33%
    2. Practitioner Development UK Ltd1× · 33%
    3. Health Academy Limited1× · 33%

    Across this category, the most active winners are CARE LINE HOMECARE LIMITED, SPRINGFIELD HOME CARE SERVICES LIMITED, Roche Diagnostics Ltd — the field to beat, or your route in as a partner.

    More from NHS Essex Integrated Care Booard

    3 listingsView all →
    AwardedHealthcare & Medical🇬🇧United Kingdom

    Primary Care Continuing Professional Development Programme

    NHS Essex ICB seeks a provider to deliver continuing professional development training for primary care staff over 12 months from April 2026.

    NHS Essex Integrated Care Booard
    Published 30 Jul 2026
    AwardedHealthcare & Medical🇬🇧United Kingdom

    Primary Care Continuing Professional Development Programme

    NHS Essex is seeking a provider to deliver Continuing Professional Development training to primary care staff over 12 months from April 2026.

    NHS Essex Integrated Care Booard
    Published 28 Jul 2026
    AwardedHealthcare & Medical🇬🇧United Kingdom

    Cardiovascular Disease Prevention Programme

    Support primary care practices in delivering enhanced cardiovascular disease prevention services focused on lipid optimisation and hypertension management over 12 months.

    NHS Essex Integrated Care Booard
    Published 30 Jun 2026

    Open in Healthcare & Medical

    4 open listingsView all →
    Healthcare & Medical🇬🇧United Kingdom

    Early Cancer Diagnostic Technologies Development Programme

    Innovate UK is investing up to £25.4 million to help develop and test early cancer diagnostic technologies, particularly for less common cancers, with projects costing £1.5-£4 million over 24-36 months.

    est.£25,400,000
    Published 1 Sept 2026
    Healthcare & Medical🇬🇧United Kingdom

    Clinical Validation of Early Cancer Diagnostic Technologies

    Innovate UK is offering up to £25.4 million to fund collaborative projects that clinically validate innovative early cancer diagnostic technologies and devices led by UK organisations including at least one SME.

    est.£25,400,000
    Published 1 Sept 2026
    OpenHealthcare & Medical🇬🇧United Kingdom

    Doxycycline 10-Pack Supply - Market Engagement 2027

    UKHSA seeks supplier information for Doxycycline 10-pack supply through a preliminary market engagement exercise under the Procurement Act 2023.

    £1nominalSecretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
    Published 21 Aug 2026
    OpenHealthcare & Medical🇬🇧United Kingdom

    Patient Diagnostic and Monitoring Electrodes - Market Engagement Survey

    Suppliers are invited to complete a preliminary market engagement questionnaire about patient diagnostic and monitoring electrodes by 21st September 2026 through eTendersNI.

    Business Services Organisation Procurement and Logistics
    Published 21 Aug 2026
    Take action
    View on sourceFind a Tender

    Award notice and full record on the publisher's site

    Publisher
    UK Cabinet Office
    Licence
    OGL v3.0
    Source
    find-tender.service.gov.uk
    Record ID
    ocds-h6vhtk-06e6d5
    NE
    Buyer
    NHS Essex Integrated Care Booard
    Sector
    Healthcare & Medical